Navigation Links
Cancer immunotherapy leader Allison to receive 2014 Szent-Gyorgyi Prize
Date:2/7/2014

to more patients in many types of cancer."

Researchers recently reported that 21 percent of patients with advanced melanoma survived to three years after taking the drug developed by Allison, with some living 10 years or longer, unheard of results for a previously untreatable terminal cancer.

"The Szent-Gyrgyi Prize is a wonderful honor and I'm gratified to receive this recognition by the NFCR, a foundation that does so much to advance cancer research," Allison said. "Ongoing recognition of checkpoint blockade immunotherapy for cancer reflects the early success and great potential of treating the immune system, rather than the tumor, to destroy cancer."

Allison will be honored at an award ceremony held April 30, 2014 at The National Press Club in Washington, D.C. Since 1973, NFCR has provided nearly $310 million in direct support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment.

Allison's research solved a crucial part of a puzzle that thwarted immunotherapy development for decades. Tumors spark an immune response, but cancer cells somehow evaded or thwarted a lethal attack by T cells white blood cells that enforce an immune response to invading infections and the body's own abnormal cells.

After launching his career and T cell research at MD Anderson, Allison moved to the University of California, Berkeley, where he identified an immune checkpoint molecule called CTLA-4 on T cells that turns them off before they can mount a successful attack on tumors that they are primed to destroy.

Moon Shots platform advances clinical and translational research

Allison developed an antibody that blocks the CTLA-4 1mmune checkpoint, unleashing a T cell attack. Ipilimumab (Yervoy) became the first drug to extend survival for patients with late-stage melanoma. It was approved by
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Credit card-sized device could analyze biopsy, help diagnose pancreatic cancer in minutes
2. MD Anderson guides intelligent redesign of cancer care delivery model
3. 3D mapping biopsy finds 3x prostate cancer of ultrasound-guided biopsy
4. Study finds dramatic rise in skin cancer among middle-aged adults
5. Researchers discover new hormone receptors to target when treating breast cancer
6. Existing medicines show promise for treating stomach and bowel cancer
7. NIH study offers insight into why cancer incidence increases with age
8. U of Maryland study: Partnership may help address cancer, health disparities
9. EBRT reduces risk of subsequent mastectomy in patients with invasive breast cancer
10. Study uncovers molecular keys to invasive bladder cancer
11. The American Cancer Society and Stand Up To Cancer announce collaborative research effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Weddingshe.com has recently announced its new collection of ... special occasion dresses for the coming new year. ... dresses for global women. Now, all the models on ... 80% off. Among the new items, the model of ... is very popular. What’s more, Weddingshe.com also provides a ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 DePuy ... a metal-on-metal version of the artificial hip system ... state and federal courts, Bernstein Liebhard LLP reports. ... Bergen County Superior Court on December 2nd, counsel ... begin deposition of plaintiffs on November 19, 2014, ...
(Date:12/20/2014)... December 20, 2014 Recently, VogueQueen.com, a ... VogueQueen Big Sale Online for 2015. Great ... All new and old consumers can get a discount, ... at the company’s website before January 30, 2015. , ... dresses and launched a prom dress promotion. Many customers ...
(Date:12/20/2014)... 2014 As Risperdal lawsuits ( ... U.S. courts, Bernstein Liebhard LLP notes the publication ... treated with the medication may experience elevated levels ... and lactation. The study, which appears in International ... who began treatment with risperidone, an antipsychotic medication ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer ... coming Christmas. In the promotion, all buyers worldwide can ... have something special for the women who are looking ... our new collections of 2015 dresses have been unveiled ... greatly discounted prices. Visit our website now before they ...
Breaking Medicine News(10 mins):Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... , THURSDAY, Dec. 1 (HealthDay News) -- ,The timing ... complications or death, a new study finds. For example, ... in the afternoon versus the morning or on Monday instead ... ease concerns that fatigue may lead to a higher rate ...
... American Society of Hematology (ASH) recognizes the following ... annual meeting in San Diego, CA, with the ... student, medical student, graduate student, resident physician, and ... Award) winners receive a $500 honorarium plus annual ...
... HealthDay Reporter , THURSDAY, Dec. 1 (HealthDay News) ... are living with HIV/AIDS than ever before in the United ... Prevention. But researchers say that,s actually good news ... treatment, rather than dying from its relentless progress. But ...
... HealthDay Reporter , THURSDAY, Dec. 1 (HealthDay ... might encourage better shut-eye: People who met national exercise ... those who didn,t. The research doesn,t confirm that ... there may be another explanation for the apparent connection ...
... resident in clinical and anatomic pathology at Boston ... Resident Leadership Representative Award from the American Society ... promoting ASCP membership and resident activities. In addition, ... Dr. Martin Kroll, won the best poster by ...
... ANTONIO Now in its 34th year, the 2011 CTRC-AACR ... in hard-to-treat populations, including patients with metastatic breast cancer, and ... symposium will be held at the Henry B. Gonzales Convention ... The symposium is presented by the Cancer Therapy & Research ...
Cached Medicine News:Health News:Time of Surgery Doesn't Influence Results, Study Says 2Health News:The American Society of Hematology announces awards honoring abstracts at 2011 Annual Meeting 2Health News:The American Society of Hematology announces awards honoring abstracts at 2011 Annual Meeting 3Health News:The American Society of Hematology announces awards honoring abstracts at 2011 Annual Meeting 4Health News:AIDS Research Holds Promise for Reducing HIV Transmission Rates 2Health News:AIDS Research Holds Promise for Reducing HIV Transmission Rates 3Health News:AIDS Research Holds Promise for Reducing HIV Transmission Rates 4Health News:More Exercise Could Make For Better Sleep: Study 2Health News:More Exercise Could Make For Better Sleep: Study 3Health News:2011 CTRC-AACR San Antonio Breast Cancer Symposium to focus on new treatments and prevention 2Health News:2011 CTRC-AACR San Antonio Breast Cancer Symposium to focus on new treatments and prevention 3
(Date:12/17/2014)...  Northstar Global Business Services, Inc. (OTCPink:MDIN) today ... made their final decision and has determined to ... effective December 15, 2014, and has resumed accepting ... book entry transfer services. All deposit restrictions have been ... fully "DTC Eligible", and has resumed electronic trading ...
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... Consulting, a business unit of PAREXEL International (Nasdaq: ... serving the biopharmaceutical and medical device industries, today released ... provide key insights into emerging areas of biosimilar development. ... Consultant and Cecil Nick, B.Sc. (Hons), Vice President, Biotechnology, ...
... of Primary Astrocytes With Anti-GLAST MicroBeads -- BERGISCH GLADBACH, Germany, September 22, 2010 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 2PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 3PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 4PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 2Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 3Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 4Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 6
The ISI Digi Grip has the strength needed for secure ,upper extremity traction....
The ApexPro CH is operational within the WMTS. It offers operating performance, up to 240 WMTS channels, and up to 120 hours of battery life....
... portable TeleMon companion monitor, and IntelliVue ... and monitoring solution for ambulating patients ... and SpO2. Clinicians can get access ... from the central station, monitoring cockpit, ...
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
Medicine Products: